SORTINE Isosorbide mononitrate 60mg modified release tablet bottle

Active ingredient:

isosorbide mononitrate, Quantity: 60 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Isosorbide mononitrate

Pharmaceutical form:

Tablet, modified release

Composition:

Excipient Ingredients: hypromellose; Carnauba Wax; stearic acid; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; macrogol 4000; colloidal anhydrous silica

Administration route:

Oral

Units in package:

30 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Prophylactic treatment of angina pectoris. SORTINE 60mg Sustained Release tablets are not recommended for the management of acute attacks of angina pectoris.

Product summary:

Visual Identification: Oval tablet with a cream coloured film coating and half scored on both sides.; Container Type: Bottle; Container Life Time: 1 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2012-04-04